Viatris to Participate in Upcoming Investor Conferences
Viatris (VTRS) will participate in fireside chats at three upcoming healthcare investor conferences in November and December 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Viatris (VTRS) will participate in fireside chats at three upcoming healthcare investor conferences in November and December 2026.
The sessions are UBS Global Biopharma on November 17 at 10 a.m. GMT / 5 a.m. ET; Jefferies Global Healthcare on November 18 at 9 a.m. GMT / 4 a.m. ET; and the 9th Annual Evercore Healthcare Conference on December 1 at 8:45 a.m. ET. Live sessions and limited-time replays will be available at investor.viatris.com.
AI-generated analysis. How Rhea-AI works. Not financial advice.
- The UBS Global Biopharma Conference on November 17, 2026, at 10 a.m. GMT / 5 a.m. ET.
- The Jefferies Global Healthcare Conference on November 18, 2026, at 9 a.m. GMT / 4 a.m. ET.
- The 9th Annual Evercore Healthcare Conference on December 1, 2026, at 8:45 a.m. ET.
Investors and the general public are invited to listen to each session at its respective time at investor.viatris.com. An archived version of each session will be available following the live event and can be accessed at the same location for a limited time.
About Viatris
Viatris Inc. (Nasdaq: VTRS) is a global healthcare company whose mission is to empower people worldwide to live healthier at every stage of life. We meet the needs of patients around the world by acting decisively with ingenuity and resolve. Whether we're developing new medicines, working to maintain a resilient supply of needed therapies, or pursuing bold innovation, we strive to deliver solutions that are effective at scale and built to endure. We're purpose-built to make an impact with a broad portfolio that spans generics, value-added medicines, established brands, and innovative medicines that address areas of significant unmet need. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on LinkedIn, Instagram, YouTube and X.
View original content to download multimedia:https://www.prnewswire.com/news-releases/viatris-to-participate-in-upcoming-investor-conferences-302935785.html
SOURCE Viatris Inc.